Project title: TARGETING ANTI CANCER AGENTS

Company name : CURE PEPTIDE LTD.

TECHNOLOGICAL FIELD
Biotechnology

KEY WORDS
Biotechnology, Analogues
of GnRH (luliberin), Carriers of cytotoxic groupings, Therapy of
tumor diseases

PROJECT SUMMARY
Every 2 minutes, in the USA, someone dies of adenocarcinoma.
Adenocarcinoma is a cancer arises from glandular tissue. It
involves cells from the lining of the walls of many different
organs of the body. The cancer of breast, lung, prostate, colon,
liver, pancreas thyroid, stomach, large intestine, gallbladder,
uterus and ovary are predominantly a type of adenocarcinoma. 55%
of all cancer cases are Adenocarcinoma.
Including: 96% of Prostate cancer.
                      96% of Breast cancer.
                      93% of Colon cancer.
                      84% of Ovarian cancer.
And, most cancer cases of: Lung, Liver, Pancreas and Thyroid.

CURE PEPTIDE LTD. developed a new and unique peptide.
The unique proprietary peptide of CURE PEPTIDE, is binding to the
adenocarcinoma cells, through typical receptors that are
over-expressed in adenocarcinoma type cancer cells.
The peptide also destroys these cancer cells, without the need to
conjugate it to chemotherapeutic substance. It holds the promise
for a very effective and safe treatment for all types of
adenocarcinoma cancer.

CURE PEPTIDE's goal is to develop, and bring to market, a drug
that is capable of:
Destroying adenocarcinoma tumors anywhere in the body.
Primary and metastasis.
At an early or advanced stage.
Significantly reduce side effects.

CURE PEPTIDE completed successfully the "Proof of Concept" stage
(both In-Vitro and In-Vivo) and is now in the Pre-Clinical stage
of its R & D.

ENTREPRENEUR
Mr. Yariv Sapir - CEO

PROJECT STATUS
The project was launched on May 2002.
Two series of pre-clinical tests are performed.

COOPERATION REQUIRED
Strategic alliance, joint venture capital.
-----------------------------------------------------------------
--------------
TEL: 972-4-8422299; 972-054-6670670, FAX 972-4-8422550, E-MAIL:
sapir@curepeptide.com WEB: www.curepeptide.com

Request for more information, about this project.

Note - you have to be registered in this server to request information. If you haven't done so yet, please:
Register in this server and your requests will be forwarded to the developer, who will contact you directly

List of projects that you already requested more information about